DORRS MARKET INTELLIGENCE

Dyne Therapeutics Reality

RDYNEquityReality

Open terminal ↗

Token price—No pricing observation available

Token market capitalization—Token market cap not supplied

Circulating supply0DORRS issuer token data

Fully diluted valuation (FDV)$0DORRS issuer token data

Reported deployment value$0DORRS valuation basis

ASSET PROFILE

Business description

CDI CDI-7121458782

Dyne Therapeutics, Inc. is a U.S. biotechnology company that develops RNA-based genetic medicines for muscle diseases such as myotonic dystrophy and Duchenne muscular dystrophy.

TRADING ACTIVITY

Last-sale transactions

Reported executions

↗

No last-sale activity to display

Executed transactions will appear here when reported by a connected source.